banter and General Discussion, page-7707

I can't think of too many falsehoods from the sceptics. I can think of a lot being routinely posted by MSB shareholders variously claiming trial success, touting partnerships and takeovers from Novartis or for Covid ARDS, Congestive Heart Failure or Discogenic Back Pain, impending/certain approval by the FDA, the quality of evidence or "acceptance of efficacy" by the FDA and incredible revenues and share prices and so on.
Then of course there are the pending class action law suits alleging the company misled investors , one of which has already been settled which suggests it was well founded.